Resultado da Busca
Há 4 dias · The layoffs were announced by BIO CEO John Crowley through an internal email, noting that the changes were meant to “better align our operations with our mission and the strategic priorities.”. Crowley was named as BIO’s new head in December 2023 and assumed the post in March 2024.
Há 5 dias · In the email, BIO CEO John Crowley said the changes are intended to “better align our operations with our mission and the strategic priorities. ... John Wilkerson. Washington Correspondent.
Há 5 dias · According to the latter outlet, BIO CEO John Crowley wrote in an email to employees that the changes are intended to “better align our operations with our mission and the strategic priorities.” The internal restructuring comes months after Crowley, an alum of Bristol Myers Squibb, Novazyme and Amicus Therapeutics, took over as CEO of the beleaguered trade group.
Há 4 dias · May 20, 2024 5:01 PM UTC. BIO President and CEO John Crowley has launched an initiative to “restructure, reorganize and reimagine” the trade association. The goal, he told BioCentury, is to increase the organization’s impact by intensifying its focus on key priorities, including patient advocacy and national security, and by revamping its ...
Há 1 dia · em maio 24, 2024. Edward Alexander Crowley, ou melhor, Aleister Crowley, nascido em Lemington, Inglaterra, em 12 de outubro de 1875, falecido em Netherwood, Hastings, em 1 de dezembro de 1947, se não foi um dos maiores ocultistas do Século XX, foi pelo menos um dos mais controvertidos. Família puritana, foi criado na seita dos Irmãos de ...
Há 1 dia · Aleister Crowley (/ ˈ æ l ɪ s t ər ˈ k r oʊ l i / AL-ist-ər KROH-lee; born Edward Alexander Crowley; 12 October 1875 – 1 December 1947) was an English occultist, philosopher, ceremonial magician, poet, painter, novelist and mountaineer.
Há 5 dias · This episode (254) features an interview with John Crowley, who shares his journey into the rare disease space. John’s involvement started in 1998 when his daughter Megan was diagnosed with Pompe disease, a rare form of muscular dystrophy. Determined to find a cure, John and his family embarked on a journey of research and entrepreneurship ...
